| Literature DB >> 28358336 |
Haichuan Wang1, Seong-Il Eyun2, Kanika Arora3, Sek Yee Tan4, Premchand Gandra5, Etsuko Moriyama6, Chitvan Khajuria7, Jessica Jurzenski8, Huarong Li9, Maia Donahue10, Ken Narva11, Blair Siegfried12.
Abstract
With Next Generation Sequencing technologies, high-throughput RNA sequencing (RNAseq) was conducted to examine gene expression in neonates of Diabrotica virgifera virgifera (LeConte) (Western Corn Rootworm, WCR) challenged with individual proteins of the binary Bacillus thuringiensis insecticidal proteins, Cry34Ab1 and Cry35Ab1, and the combination of Cry34/Cry35Ab1, which together are active against rootworm larvae. Integrated results of three different statistical comparisons identified 114 and 1300 differentially expressed transcripts (DETs) in the Cry34Ab1 and Cry34/35Ab1 treatment, respectively, as compared to the control. No DETs were identified in the Cry35Ab1 treatment. Putative Bt binding receptors previously identified in other insect species were not identified in DETs in this study. The majority of DETs (75% with Cry34Ab1 and 68.3% with Cry34/35Ab1 treatments) had no significant hits in the NCBI nr database. In addition, 92 DETs were shared between Cry34Ab1 and Cry34/35Ab1 treatments. Further analysis revealed that the most abundant DETs in both Cry34Ab1 and Cry34/35Ab1 treatments were associated with binding and catalytic activity. Results from this study confirmed the nature of these binary toxins against WCR larvae and provide a fundamental profile of expression pattern of genes in response to challenge of the Cry34/35Ab1 toxin, which may provide insight into potential resistance mechanisms.Entities:
Keywords: Bt challenge; Diabrotica virgifera virgifera; Next Generation Sequencing (NGS); differential gene expression
Mesh:
Substances:
Year: 2017 PMID: 28358336 PMCID: PMC5408198 DOI: 10.3390/toxins9040124
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1MA plots of differential expression in each treatment comparison with DESeq method. (a) buffer vs. Cry35Ab1; (b) buffer vs. Cry34Ab1; (c) buffer vs. Cry34/Cry35Ab1. Red dots represent the genes either up- or down-regulated at p (adj) < 0.05. MA plot is a way to display deferentially expressed genes versus expression strength (log2 fold change) between control and treatment.
RNAseq differential gene expression for WCR exposed to Cry34/35Ab1 toxin.
| Analysis Method | Cry34Ab1 vs. Buffer | Cry35Ab1 vs. Buffer | Cry34Ab1 + Cry35Ab1 vs. Buffer | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| up | down | total | Shared * | up | down | total | up | down | total | shared | |
| 44 | 72 | 116 | 114 | 0 | 0 | 0 | 992 | 1223 | 2215 | 1300 | |
| 49 | 83 | 132 | 0 | 0 | 0 | 647 | 1026 | 1673 | |||
| 48 | 87 | 135 | 0 | 0 | 0 | 1093 | 1243 | 2336 | |||
* indicate the total DETs shared among three analysis method.
Number of DETs shared and not shared between Cry34Ab and Cry34Ab1 + Cry35Ab1 treatment.
| Category | Category | # Contigs | Digital Expression in Fold Change * | ||
|---|---|---|---|---|---|
| up-regulated | shared | 31 | 2.55 (2–4.66) a | 4.5 (2.3–12.5) b | |
| unique | 12 a | 534 b | 2.36 (2.14–2.9) a | 2.69 (2–64) b | |
| down-regulated | Shared | 61 | 2.64 (2–5.6) a | 10.6 (2.49–194) b | |
| unique | 10 a | 674 b | 3.16 (2–1) a | 3.3 (2–88) b | |
a challenged with Cry34Ab; b challenged with combination of Cry34/35Ab1; * all fold changes are from DESeq data at p < 0.05).
Figure 2Blast hit of DGEs. (a) top BLAST hits of DGEs in WCR neonates exposed to Cry34/35Ab1 combination; (b) top BLAST hits of DGEs in WCR neonates exposed to Cry34Ab1 alone.
Figure 3GO term categorization and distribution in Cry34Ab1 compared to control at level 2 under three main categories, i.e., biological process, molecular function and cellular component.
Figure 4GO term categorization and distribution in Cry34/35Ab1 vs. buffer control at level 2 under three main categories, i.e. biological process, molecular function and cellular component.
Comparison of expression of four randomly selected genes with two analysis methods.
| Category | Gene | Fold in RNAseq Analysis | Fold Change in qPCR |
|---|---|---|---|
| up-regulated | GSC | 12.55 * | 91.01 * |
| PAT | 8.69 * | 3.44 * | |
| down-regulated | GH45 | 32 * | 0.31 * |
| ALP | 7.4 * | 0.16 * |
* The fold change either in RNAseq analysis or qPCR was from Cry34/35-treated samples and was compared to the expression of the same gene from the control; Abbreviation: GSC-gut-specific chitinase, PAT-proton-coupled amino acid transporter 1-like, GH45-endo-beta glucansase and ALP-alkaline phosphatase.